Characteristics of secondary, primary, and compensated hypogonadism in aging men: Evidence from the European male ageing study

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 4, 2010, Pages 1810-1818

  Tajar, Abdelouahid ^a,m   Forti, Gianni ^b,m   O'Neill, Terence W ^a,m   Lee, David M ^a,m   Silman, Alan J ^a,m   Finn, Joseph D ^a,m   Bartfai, György ^c,m   Boonen, Steven ^d,m   Casanueva, Felipe F ^e,m   Giwercman, Aleksander ^f,m   Han, Thang S ^g   Kula, Krzysztof ^h,m   Labrie, Fernand ⁱ   Lean, Michael E J ^j   Pendleton, Neil ^a   Punab, Margus ^k,m   Vanderschueren, Dirk ^d,m   Huhtaniemi, Ilpo T ^l,m   Wu, Frederick C W ^a,m   Petrone, Luisa ^m   Corona, Giovanni ^m   Borghs, Herman ^m   Slowikowska Hilczer, Jolanta ^m   Walczak Jedrzejowska, Renata ^m   Steer, Philip ^m   Pye, Stephen ^m   Lage, Mary ^m   Földesi, Imre ^m   Fejes, Imre ^m   Korrovitz, Paul ^m   Jiang, Ming ^m   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^h MEDICAL UNIVERSITY OF LODZ   (Poland)

ⁱ UNIVERSITÉ LAVAL   (Canada)

^j UNIVERSITY OF GLASGOW   (United Kingdom)

^k TARTU UNIVERSITY CLINICS   (Estonia)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m Hammersmith Campus ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

LUTEINIZING HORMONE; TESTOSTERONE; ESTRADIOL;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CLINICAL FEATURE; COMMUNITY; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ERECTILE DYSFUNCTION; EUROPE; GONAD; HEALTH STATUS; HUMAN; HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SYMPTOM; TESTOSTERONE BLOOD LEVEL; ANTHROPOMETRY; BLOOD; CAUCASIAN; CLINICAL TRIAL; DRINKING BEHAVIOR; MIDDLE AGED; MOTOR ACTIVITY; MULTICENTER STUDY; PHYSIOLOGY; QUESTIONNAIRE; REGRESSION ANALYSIS; SMOKING;

ADULT; AGED; AGING; ALCOHOL DRINKING; ANTHROPOMETRY; CROSS-SECTIONAL STUDIES; ERECTILE DYSFUNCTION; ESTRADIOL; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEALTH STATUS; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; TESTOSTERONE;

EID: 77951642063     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1796     Document Type: Article

References (39)

1. Gray A, Feldman HA, McKinlay JB, Longcope C 1991 Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 73:1016-1025
2. Orwoll E, Lambert LC, Marshall LM, Phipps K, Blank J, Barrett-Connor E, Cauley J, Ensrud K, Cummings S 2006 Testosterone and estradiol among older men. J Clin Endocrinol Metab 91:1336-1344
3. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D 2008 Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93:2737-2745
4. Snyder PJ 2004 Hypogonadism in elderly men: what to do until the evidence comes. N Engl J Med 350:440-442
5. Bhasin S, Wu F 2006 Making a diagnosis of androgen deficiency in adult men: what to do until all the facts are in? Nat Clin Pract Endocrinol Metab 2:529
6. Nieschlag E, Swerdloff R, Behre HM, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morley JE, Schulman C, Wang C, Weidner W, Wu FC 2006 Investigation, treatment, and monitoring of lateonset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl 27:135-137
7. Jones TH 2009 Late onset hypogonadism. BMJ 338:b352
8. Liverman C, Blazer DG 2004 Testosterone and Aging Clinical Research Directions. Washington DC: Institute of Medicine of the National Academies
9. Härkönen K, Huhtaniemi I, Mäkinen J, Hübler D, Irjala K, Koskenvuo M, Oettel M, Raitakari O, Saad F, Pöllänen P 2003 The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 26:187-194
10. van den Beld A, Huhtaniemi IT, Pettersson KS, Pols HA, Grobbee DE, de Jong FH, Lamberts SW 1999 Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab 84:1334-1339
11. Cooper DS 1987 Subclinical hypothyroidism. JAMA 258:246-247
12. Vaidya B, Pearce SH 2008 Management of hypothyroidism in adults. BMJ 337:a801
13. Lee DM, O'Neill TW, Pye SR, Silman AJ, Finn JD, Pendleton N, Tajar A, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D, Wu FC 2009 The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl 32:11-24
14. Ware JE, Kosinski M, Keller S 1994 SF-36 physical and mental summary scales: a user's manual. Boston, MA: The Health Institute, New England Medical Center
15. O'Connor DB, Corona G, Forti G, Tajar A, Lee DM, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Huhtaniemi IT, Kula K, O'Neill TW, Pendleton N, Punab M, Silman AJ, Vanderschueren D, Wu FC 2008 Assessment of sexual health in aging men in Europe: development and validation of the European Male Ageing Study sexual function questionnaire. J Sex Med 5:1374-1385
16. Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J 2006 Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 99:182-188
17. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672 (Pubitemid 30645223)
18. Vermeulen A 2005 Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays. J Endocrinol Invest 28:28-31
19. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB 2007 Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92:4241-4247
20. Kreft I., de Leeuw J 1998 Introducing multilevel models. London: Saga
21. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC 2008 Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159:507-514
22. Svartberg J, Jorde R 2007 Measuring gonadotropins is of limited value in detecting hypogonadism in ageing men: the Tromso study. Int J Androl 30:445-451
23. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB 2007 The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92:549-555
24. Cohen PG 2001 Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses 56:702-708
25. Porte Jr D, Baskin DG, Schwartz MW 2005 Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 54:1264-1276
26. Pittas AG, Joseph NA, Greenberg AS 2004 Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89:447-452
27. Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J, Rissanen A 2004 Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab 6:208-215 (Pubitemid 38559701)
28. de Boer H, Verschoor L, Ruinemans-Koerts J, Jansen M 2005 Letrozole normalizes serum testosterone in severely obese men with hypogonadotropic hypogonadism. Diabetes Obes Metab 7:211-215
29. Neaves WB, Johnson L, Porter JC, Parker Jr CR, Petty CS 1984 Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 59:756-763 (Pubitemid 14012503)
30. Perheentupa A, Huhtaniemi I 2009 Aging of the human ovary and testis. Mol Cell Endocrinol 299:2-13
31. Bhasin S, Enzlin P, Coviello A, Basson R 2007 Sexual dysfunction in men and women with endocrine disorders. Lancet 369:597-611
32. Travison TG, Morley JE, Araujo AB, O'Donnell AB, McKinlay JB 2006 The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 91:2509-2513
33. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Mac RP, Lee M, Yarasheski KE, Sinha-Hikim I, Dzekov C, Dzekov J, Magliano L, Storer TW 2005 Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab 90:678-688
34. Zitzmann M, Faber S, Nieschlag E 2006 Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91:4335-4343
35. Liu PY, Pincus SM, Takahashi PY, Roebuck PD, Iranmanesh A, Keenan DM, Veldhuis JD 2006 Aging attenuates both the regularity and joint synchrony of LH and testosterone secretion in normal men: analyses via a model of graded GnRH receptor blockade. Am J Physiol Endocrinol Metab 290:E34-E41
36. Biondi B, Cooper DS 2008 The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76-131
37. Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, Braverman LE 2002 Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 87:3221-3226
38. Weetman AP 2008 Abnormal thyroid stimulating hormone levels: when and who to treat. Clin Med 8:208-211
39. Vermeulen A, Verdonck G 1992 Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab 74:939-942